INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc – MREO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc – MREO GlobeNewswire January 13, 2026 NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO). Such investors are advised to […]

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investorsof Bgin Blockchain Limited – BGIN

(NasdaqGM:BGIN), NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Bgin Blockchain Limited (“Bgin” or the “Company”) (NASDAQ: BGIN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Bgin and certain of its officers and/or directors have engaged in securities

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investorsof Bgin Blockchain Limited – BGIN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investorsof Bgin Blockchain Limited – BGIN GlobeNewswire January 13, 2026 NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Bgin Blockchain Limited (“Bgin” or the “Company”) (NASDAQ: BGIN).  Such investors are advised to contact Danielle Peyton at

Match Group to Announce Fourth Quarter and Full Year 2025 Results

Match Group (NASDAQ: MTCH) will release financial results for the fourth quarter and full year 2025 on Tuesday, February 3, 2026 after-market close. The company will host its quarterly conference call to discuss these results at 5:00 p.m. ET on the same day. A live webcast of the conference call, along with supplemental investor materials,

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutanix, Inc. – NTNX

(NASDAQ:NTNX), NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Nutanix, Inc. (“Nutanix” or the “Company”) (NASDAQ: NTNX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Nutanix and certain of its officers and/or directors have engaged

CEO Angela Roberts Joins U.S. Money Reserve President Philip N. Diehl to Celebrate the Opening of New Corporate Headquarters in Austin, Texas

U.S. Money Reserve, one of the nation’s largest precious metals distributors, today announces the official opening of its new corporate headquarters in Austin, Texas. The celebration was formally marked by a ribbon-cutting ceremony led by U.S. Money Reserve’s Chief Executive Officer, Angela Roberts; Philip N. Diehl, President of U.S. Money Reserve; and Edmund C. Moy,

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutanix, Inc. – NTNX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutanix, Inc. – NTNX GlobeNewswire January 13, 2026 NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Nutanix, Inc. (“Nutanix” or the “Company”) (NASDAQ: NTNX). Such investors are advised to contact Danielle Peyton at

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. – ORGO

(NASDAQ:ORGO), NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Organogenesis and certain of its officers and/or directors have

Array completes sale of select spectrum assets to AT&T for $1.018 billion

Board declares special dividend of $10.25 per share Array Digital Infrastructure, Inc.SM (NYSE: AD) (ArraySM) today announced the successful closing of the previously announced agreement with AT&T (NYSE: T) to sell a portion of the Company's retained spectrum licenses for total consideration of $1.018 billion. The transaction furthers the objective announced on May 28, 2024,

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. – ORGO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. – ORGO GlobeNewswire January 13, 2026 NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO). Such investors are advised to contact Danielle

Scroll to Top